Eileen M. Shore, Ph.D.
Research Professor of Orthopaedic Surgery
Department: Orthopaedic Surgery
Graduate Group Affiliations
Contact information
University of Pennsylvania
Department of Orthopaedic Surgery
424 Stemmler Hall
Philadelphia, PA 19104-6081
Department of Orthopaedic Surgery
424 Stemmler Hall
Philadelphia, PA 19104-6081
Office: 215-898-2331
Fax: 215-573-2133
Fax: 215-573-2133
Email:
SHORE@MAIL.MED.UPENN.EDU
SHORE@MAIL.MED.UPENN.EDU
Publications
Education:
B.S. (Biology)
University of Notre Dame, South Bend, Indiana, 1976.
M.A. (Biology)
Indiana University, Bloomington, Indiana, 1978.
Ph.D. (Cell and Molecular Biology)
University of Pennsylvania, Philadelphia, PA, 1987.
Permanent linkB.S. (Biology)
University of Notre Dame, South Bend, Indiana, 1976.
M.A. (Biology)
Indiana University, Bloomington, Indiana, 1978.
Ph.D. (Cell and Molecular Biology)
University of Pennsylvania, Philadelphia, PA, 1987.
Description of Research Expertise
RESEARCH INTERESTS:Genetic Regulation of Bone Formation: Genetic diseases of bone formation and development. Molecular and cell biology of bone formation and osteoblast differentiation. Cell signaling pathways and transcriptional activation and regulation of bone morphogenetic protein (BMP) and GNAS target genes. Developmental biology of BMP signaling.
KEY WORDS:
Bone formation, cell differentiation, human genetics, molecular biology, cell biology, developmental biology, gene expression, inherited diseases, bone, cartilage, bone morphogenetic protein, BMP, ACVR1, G-proteins, GNAS, FOP, POH.
DESCRIPTION OF RESEARCH:
Research in our laboratory is focused on genetic diseases of bone formation, mainly fibrodysplasia ossificans progressiva (FOP) and progressive osseous heteroplasia (POH). Both of these rare disorders are characterized by de novo formation of bone: in FOP, the ectopic bone forms in deep connective tissues such as muscle; and in POH, bone formation initiates within the skin. Our goals are to investigate the genetic causes of these conditions and the cellular pathways that are involved in the induction of bone development and formation, and to use this information to develop treatments for these and other disorders of bone.
With our identification of the mutated genes for POH and FOP, our experimental directions are focused on determining the functions of these genes and the consequences of the identified mutations.
POH is caused by heterozygous inactivating mutations in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase (GNAS). Our data suggest that phenotypic expression of a GNAS mutation may be affected by genomic imprinting. GNAS is a complex gene that encodes multiple transcripts regulated by different promoters. Active areas of investigation include: genetics and epigenetics of GNAS and POH; the roles of GNAS expression in bone cell differentiation; and investigation of the signal transduction pathways mediated by GNAS proteins.
Linkage analysis of families with inheritance of FOP identified a common mutation (R206H) in the ACVR1 gene in patients with classic features of the disease. ACVR1 encodes a BMP type I receptor. Areas of investigation include the genetics and gene regulation of FOP, for example, loss of heterozygosity (LOH) within the candidate interval has been identified in one patient and may include a regulatory region for ACVR1; and recent studies examined the ACVR1 gene in patients with very severe or mild forms of FOP and identified novel ACVR1 mutations that suggest genotype-phenotype correlations. We are also investigating the effects of FOP ACVR1 mutations on the BMP signaling pathway and roles in cartilage and bone cell differentiation. Mouse and zebrafish models are being used to investigate the developmental biology of ACVR1 signaling in bone and cartilage as well as other tissues during vertebrate development.
In addition, we are using cell lineage-tracing analyses to investigate the source and identity of the cells that are induced to differentiate into cartilage and/or bone in FOP and POH. We are interested in identifying the earliest cellular events that occur during the induction of bone formation.
Translational studies and drug development are an increasing focus within the lab. Animal models for FOP and POH will be used to evaluate gene therapy and other strategies to treat these conditions.
LAB ROTATION PROJECTS FOR 2009-2010:
Rotation projects are available in most of the research areas described in the Research Summary. Specific projects will be discussed individually. Laboratory research is closely tied to clinical observation and patient care, and students are encouraged to have patient contact.
LAB PERSONNEL: (as of Summer 2009)
Collaborators: Frederick S. Kaplan MD, David Glaser MD, Robert J. Pignolo, MD, PhD
Students: Andria Culbert (CAMB); Andrew Smith (undergrad); Edwin Theosmy (undergrad)
Post-doc/Research Associates: Salin Chakkalakal PhD; Josef Kaplan PhD; Vitali Lounev PhD; Shengliang Zhang PhD; Haitao Wang PhD
Research Specialists: Bob Caron; Ruth McCarrick-Walmsley; Meiqi Xu; Deyu Zhang
Selected Publications
Muglu, J.A., A. Garg, T. Pandiarajan, E.M. Shore, F.S. Kaplan, D. Uchil, and M.J. Dickson: Pregnancy in fibrodysplasia ossificans progressiva. Obstet. Med. in press (online publ Dec 2011) December 2011.Kaplan, J., F.S. Kaplan, and E.M. Shore : Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting. Gene Therapy October 2011.
Kan, L.,V.Y. Lounev, R.J. Pignolo, L. Duan, Y. Liu, S.R. Stock, T.L. McGuire, B. Lu, N.P. Gerard, E.M. Shore, F.S. Kaplan and J.A. Kessler.: Substance P signaling mediates BMP-dependant heterotopic ossification. J. Cellular Biochemistry; online July 11 2011.
Shore, E.M. and F.S. Kaplan : Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva. Current Osteoporosis Reports 9(2): 83-88 June 2011.
Groppe, J.C., J. Wu, E.M. Shore, F.S. Kaplan.: In vitro analysis of the Dysregulated R206H ALK2 Kinase-FKBP12 interaction associated with heterotopic ossification in FOP. Cell Tissue Organs April 28 2011.
Pignolo, R.J., M. Xu, E. Russell, A. Richardson, J. Kaplan, P.C. Billings, F.S. Kaplan, E.M. Shore.: Heterozygous inactivation of Gnas confers enhanced osteogenic differentiation and formation of heterotopic ossification. JBMR 2011.
Medici, D., E.M. Shore, V.Y. Lounev, F.S. Kaplan, R. Kalluri, and B.R. Olsen : Conversion of vascular endothelial cells into multipotent stem-like cells. Nature Medicine 16(12): 1400-1406, December 2010 Notes: Epub 2010 Nov 21 Erratum in: Nat Med 2011 Apr;17(4):514.
Kartal, M. E.M. Shore, M. Xu, L. Schwering, M. Uhl, R. Korinthenberg, C. Niemeyer, F.S. Kaplan, M. Lauten : Brief Report: Fibrodysplasia ossificans progressiva (FOP): Watch the great toes! Eur. J. Pediatr 169(11): 1417-1421, November 2010.
Shore, E.M. and F.S. Kaplan : Inherited Human Diseases of Heterotopic Bone Formation. Nature Reviews Rheumatology 6(9): 518-527, September 2010 Notes: Epub 2010 August 10.
Kaplan, F.S., M.A. Zasloff, J.A. Kitterman, E.M. Shore, C.C. Hong, D. Rocke : Early Mortality from cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J. Bone Joint Surg. 92(3): 686-691, March 2010 Notes: PMCID# 2827822.

